Horizon Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

Horizon Bancorp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34K	Hold	181	–	–	0.02%	125
2026 Q1	$31K	Hold	181	–	–	0.01%	129
2025 Q4	$31K	Hold	181	–	–	0.02%	127
2025 Q3	$26K	Hold	181	–	–	0.01%	130
2025 Q2	$23K	Hold	181	–	–	0.01%	160
2025 Q1	$23K	Sell	181 -109	-38%	-$14.8K	0.01%	130
2024 Q4	$38K	Sell	290 -55	-16%	-$7.73K	0.02%	128
2024 Q3	$50K	Hold	345	–	–	0.02%	127
2024 Q2	$47K	Hold	345	–	–	0.02%	131
2024 Q1	$47K	Sell	345 -11	-3%	-$1.5K	0.02%	143
2023 Q4	$48K	Hold	356	–	–	0.02%	144
2023 Q3	$44K	Buy	+356	New	+$45.3K	0.03%	135
2023 Q2	–	Sell	-636	Closed	-$82K	–	238
2023 Q1	$82K	Hold	636	–	–	0.05%	79
2022 Q4	$84K	Buy	+636	New	+$82.2K	0.05%	111
2020 Q3	$169K	Hold	1,251	–	–	0.24%	119
2020 Q2	$171K	Sell	1,251 -152	-11%	-$19.4K	0.18%	116
2020 Q1	$151K	Sell	1,403 -54	-4%	-$6.22K	0.23%	114
2019 Q4	$176K	Buy	+1,457	New	+$163K	0.17%	155

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Horizon Bancorp's IBB Position: Q2 2026 in Review

Horizon Bancorp held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 181 shares worth $34K. The position accounts for 0.02% of the portfolio, ranked #125.

Horizon Bancorp first reported a position in IBB in Q4 2019 and has held it in 18 quarters since. The position peaked at $176K in Q4 2019. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Horizon Bancorp held 181 shares of iShares Biotechnology ETF worth $34K as of Q2 2026.
Horizon Bancorp left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.02% of Horizon Bancorp's portfolio in Q2 2026, its #125 holding.
Horizon Bancorp first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 18 quarters since.
Horizon Bancorp's iShares Biotechnology ETF position peaked at $176K in Q4 2019.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Horizon Bancorp's 13F filing for Q2 2026, filed 4 Aug 2026.